Targeting Tumors with Resealable Nanovesicles Permeabilized by NIR Light
利用近红外光透化的可重新密封纳米囊泡靶向肿瘤
基本信息
- 批准号:8609764
- 负责人:
- 金额:$ 38.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-19 至 2018-08-31
- 项目状态:已结题
- 来源:
- 关键词:Antineoplastic AgentsBiocompatibleBiodistributionBiologicalBiological ProcessBiotinBlood CirculationBlood flowBody TemperatureBuffaloesCaliberDepositionDoxorubicinDrug Delivery SystemsEnvironmentExposure toFiber OpticsHeartHeatingHumanIn VitroIonsLabelLeadLightLiposomesMalignant NeoplasmsMedicalMembraneMethodsNude MicePenetrationPermeabilityPharmaceutical PreparationsPhospholipidsPhysiologicalPorphyrinsProceduresProcessProteinsRecoveryRetrievalSamplingSideSiteSolid NeoplasmSolutionsStimulusSystemTechnologyTemperatureTherapeuticTimeTissuesUniversitiesVesicleXenograft procedurebasechemical reactioncontrolled releaseirradiationmonomernanocarriernanoparticlenanoscalenanovesiclenovelnovel strategiespH gradientpreventpublic health relevanceresearch studyresponsesealtumorunilamellar vesicle
项目摘要
PROJECT SUMMARY
At present, few synthetic systems can achieve robust, on-demand spatial and temporal control of micro or
nanovesicle permeabilization in biological environments. We propose to build upon proof-of-principle
experiments establishing the feasibility of such a membrane permeabilization system and to apply this
technology towards: 1) triggering drug release in tumors and 2) capturing tumor microvasculature contents via
a remote loading and retrieval approach. Several methods for cargo release driven by external stimuli driven
have been proposed; whereas to our knowledge the concept of remote capture and retrieval of microvessel
contents using triggered permeability in nanovesicles has not yet been explored. So far, essentially all
biocompatible approaches for externally triggered membrane permeabilization from nanocarriers comprise
systems that release their contents when the surrounding temperatures are raised by a few degrees above
body temperature via direct or indirect heating. However, such mechanisms are not amenable to trigger-side
release modulation and the narrow thermal operating window precludes carrier stability at physiological
temperatures. Furthermore, the lack of stability in physiological conditions prevents more demanding
applications of these materials such as triggered release at later time points as well as remote loading and
recovery. Here, we propose a fundamentally new controlled release system based on porphyrin-
phospholipid doped (PoPD) liposomes transiently permeabilized directly by near infrared (NIR) light, a
clinically-applicable stimulus that has negligible actuation in the "off state" and minimal interference with
biological tissues. The ability to open and close nanovesicles in the body with precise spatial and temporal
control could lead to entirely new approaches to treating and understanding cancer. We synthesized a novel
light-absorbing monomer esterified from clinically approved components that gave rise to highly stable
porphyrin bilayer. Remarkably, rapid and complete cargo release was induced upon brief exposure to mild NIR
irradiation using an optimal porphyrin-phospholipid (but not free porphyrin) doping. Unlike previously described
systems, release occurred in the absence of bulk solution photothermal heating or chemical reactions. In
physiological conditions in vitro, NIR irradiation induced a 25,000 fold increase in the release rate of
actively loaded doxorubicin, orders of magnitude greater than previously described triggered release
methods. Induced permeability could be used for both unloading and loading cargo, and could be modulated
by varying porphyrin doping, irradiation intensity and irradiation duration for highly tunable manipulation of
permeabilization. This project has three specific aims. Aim 1: Develop micro and nanovesicles that open and
close on demand in response to NIR light;. Aim 2: Use near infrared light to deliver cancer therapeutics to
tumors; Aim 3: Sample tumor microvasculature contents using a capture and retrieve strategy.
项目概要
目前,很少有合成系统能够实现对微观或时间的鲁棒、按需空间和时间控制。
生物环境中的纳米囊泡透化。我们建议以原理验证为基础
实验建立了这种膜透化系统的可行性并应用该系统
技术目标:1)触发肿瘤中的药物释放,2)通过捕获肿瘤微血管内容物
远程加载和检索方法。外部刺激驱动货物释放的几种方法
已被提议;而据我们所知,远程捕获和检索微血管的概念
尚未探索使用纳米囊泡中触发渗透性的内容。到目前为止,基本上所有
用于纳米载体外部触发膜透化的生物相容性方法包括
当周围温度升高几度时释放其内容物的系统
通过直接或间接加热来调节体温。然而,此类机制不适合触发方
释放调节和狭窄的热操作窗口妨碍了载体在生理条件下的稳定性
温度。此外,生理条件缺乏稳定性阻碍了更高的要求
这些材料的应用,例如稍后时间点的触发释放以及远程加载和
恢复。在这里,我们提出了一种基于卟啉的全新控释系统
磷脂掺杂 (PoPD) 脂质体直接通过近红外 (NIR) 光瞬时透化,
临床上适用的刺激,在“关闭状态”下的驱动可以忽略不计,并且干扰最小
生物组织。以精确的空间和时间打开和关闭体内纳米囊泡的能力
控制可能会带来治疗和理解癌症的全新方法。我们综合了一部小说
由临床批准的成分酯化的吸光单体,产生高度稳定的
卟啉双层。值得注意的是,短暂暴露于温和的近红外光下会诱导快速且完全的货物释放
辐照使用最佳卟啉-磷脂(但不是游离卟啉)掺杂。与之前描述的不同
系统中,释放是在没有本体溶液光热加热或化学反应的情况下发生的。在
在体外生理条件下,近红外辐射导致释放速率增加 25,000 倍
主动加载的阿霉素,比之前描述的触发释放大几个数量级
方法。诱导渗透率可用于卸载和装载货物,并且可以调节
通过改变卟啉掺杂、辐照强度和辐照持续时间,可实现高度可调的操作
透化。该项目有三个具体目标。目标 1:开发可打开和释放的微米和纳米囊泡
响应近红外光按需关闭;目标 2:使用近红外光向癌症患者提供癌症治疗
肿瘤;目标 3:使用捕获和检索策略对肿瘤微血管内容物进行采样。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(3)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan F Lovell其他文献
異なる2つのステージを標的とするマラリアワクチンの開発に向けて
开发针对两个不同阶段的疟疾疫苗
- DOI:
- 发表时间:
2022 - 期刊:
- 影响因子:0
- 作者:
Wei-Chiao Huang;Moustafa T Mabrouk;Luwen Zhou;馬場 みなみ;橘 真由美;鳥居 本 美;高島 英造;Emily Locke;Jordan Plieskatt;C Richter King;Camila H Coelho;Patrick E Duffy;Carole Long;坪井 敬文;三浦 憲豊;Yimin Wu;石野 智子;Jonathan F Lovell - 通讯作者:
Jonathan F Lovell
Molecular mechanisms of sporozoite transmission to mammals, the target of the first malaria vaccine
子孢子传播给哺乳动物的分子机制,这是第一个疟疾疫苗的目标
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
Wei-Chiao Huang;Moustafa T Mabrouk;Luwen Zhou;馬場 みなみ;橘 真由美;鳥居 本 美;高島 英造;Emily Locke;Jordan Plieskatt;C Richter King;Camila H Coelho;Patrick E Duffy;Carole Long;坪井 敬文;三浦 憲豊;Yimin Wu;石野 智子;Jonathan F Lovell;Tomoko Ishino.;Tomoko Ishino.;Tomoko ISHINO - 通讯作者:
Tomoko ISHINO
Jonathan F Lovell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan F Lovell', 18)}}的其他基金
Developing a Multivalent Subunit Particle Vaccine Against Tuberculosis
开发抗结核病多价亚单位颗粒疫苗
- 批准号:
10598146 - 财政年份:2022
- 资助金额:
$ 38.94万 - 项目类别:
Developing a Multivalent Subunit Particle Vaccine Against Tuberculosis
开发抗结核病多价亚单位颗粒疫苗
- 批准号:
10441958 - 财政年份:2022
- 资助金额:
$ 38.94万 - 项目类别:
Light-Triggered Drug Release in Primed Pancreatic Tumors
胰腺肿瘤中的光触发药物释放
- 批准号:
8562197 - 财政年份:2013
- 资助金额:
$ 38.94万 - 项目类别:
Targeting Tumors with Resealable Nanovesicles Permeabilized by NIR Light
利用近红外光透化的可重新密封纳米囊泡靶向肿瘤
- 批准号:
8737994 - 财政年份:2013
- 资助金额:
$ 38.94万 - 项目类别:
Targeting Tumors with Resealable Nanovesicles Permeabilized by NIR Light
利用近红外光透化的可重新密封纳米囊泡靶向肿瘤
- 批准号:
9135540 - 财政年份:2013
- 资助金额:
$ 38.94万 - 项目类别:
Light-Triggered Drug Release in Primed Pancreatic Tumors
胰腺肿瘤中的光触发药物释放
- 批准号:
9130825 - 财政年份:2013
- 资助金额:
$ 38.94万 - 项目类别:
Chemophototherapy with Porphyrin-phospholipid Liposomes Permeabilized by Red Light
使用红光透化的卟啉磷脂脂质体进行化学光疗
- 批准号:
10190938 - 财政年份:2013
- 资助金额:
$ 38.94万 - 项目类别:
Light-Triggered Drug Release in Primed Pancreatic Tumors
胰腺肿瘤中的光触发药物释放
- 批准号:
8717660 - 财政年份:2013
- 资助金额:
$ 38.94万 - 项目类别:
相似国自然基金
基于α-氨基酮衍生物的高效生物相容性光聚合引发体系的构建及其机理研究
- 批准号:22361019
- 批准年份:2023
- 资助金额:33 万元
- 项目类别:地区科学基金项目
钛合金表面高生物相容性涂层的绿色制备及性能研究
- 批准号:52261017
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
多孔钛合金椎间融合器的生物相容性及成骨性与置钉体系作用机制研究
- 批准号:32260235
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
含中药活性组分的生物相容性离子液体的合成、性质及与蛋白质的相互作用
- 批准号:22173084
- 批准年份:2021
- 资助金额:57 万元
- 项目类别:面上项目
基于表面理化性质精准调控的医用钛合金制备及生物相容性研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNGTUMOR RECURRENCE
用于预防肺部肿瘤复发的超疏水载药支撑
- 批准号:
10331020 - 财政年份:2019
- 资助金额:
$ 38.94万 - 项目类别:
SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNG TUMOR RECURRENCE
用于预防肺肿瘤复发的超疏水载药支撑
- 批准号:
10083724 - 财政年份:2019
- 资助金额:
$ 38.94万 - 项目类别:
SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNGTUMOR RECURRENCE
用于预防肺部肿瘤复发的超疏水载药支撑
- 批准号:
10553156 - 财政年份:2019
- 资助金额:
$ 38.94万 - 项目类别:
Image-Guided Drug Delivery and Treatment for GIST
图像引导胃肠道间质瘤的药物输送和治疗
- 批准号:
9792375 - 财政年份:2018
- 资助金额:
$ 38.94万 - 项目类别:
Development of Catch and Release Approach for Multi-Drug Local Delivery of Chemotherapies
多药物局部化疗递送捕获和释放方法的开发
- 批准号:
9759886 - 财政年份:2018
- 资助金额:
$ 38.94万 - 项目类别: